Person:
Yang, Pan

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Yang

First Name

Pan

Name

Yang, Pan

Filters

2021 - 20242

Settings

Author's Publications: search.filters.isAuthorOfPublication.159b75cb-2a82-4eea-b686-5b67dbed4c9d

Search Results

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Publication
    Shifts in receptors during submergence of an encephalitic arbovirus
    (Springer Science and Business Media LLC, 2024-07-24) Li, Wanyu; Plante, Jessica A.; Lin, Chieyu; Basu, Himanish; Plung, Jesse S.; Fan, Xiaoyi; Boeckers, Joshua M.; Oros, Jessica; Buck, Tierra K.; Anekal, Praju V.; Hanson, Wesley A.; Varnum, Haley; Wells, Adrienne; Mann, Colin J.; Tjang, Laurentia V.; Yang, Pan; Reyna, Rachel A.; Mitchell, Brooke M.; Shinde, Divya P.; Walker, Jordyn L.; Choi, So Yoen; Brusic, Vesna; Montero Llopis, Paula; Weaver, Scott C.; Umemori, Hisashi; Chiu, Isaac M.; Plante, Kenneth S.; Abraham, Jonathan
    Western equine encephalitis virus (WEEV) is an arthropod-borne virus (arbovirus) that frequently caused major outbreaks of encephalitis in humans and horses in the early 20th century, but outbreak frequency has since decreased drastically, and strains of this alphavirus isolated in the last two decades are less virulent in mammals than strains isolated in the 1930s–40s. The basis for this phenotypic change in WEEV strains and coincident decrease in epizootic activity (“viral submergence") is unclear, as is the possibility of re-emergence of highly virulent strains. Here, we identified protocadherin 10 (PCDH10), as a cellular receptor for WEEV. We show that multiple highly virulent ancestral WEEV strains isolated in the 1930s–1940s, in addition to binding human PCDH10, could also bind very low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2), which are recognized by another encephalitic alphavirus as receptors. However, while most of the WEEV strains we examined bind to PCDH10, a contemporary strain lost the ability to recognize mammalian PCDH10 while retaining the ability to bind avian receptors, suggesting WEEV adaptation to a main reservoir host during enzootic circulation. PCDH10 supports WEEV E2–E1-mediated infection of primary murine cortical neurons and administration of a soluble form of PCDH10 protects mice from lethal WEEV challenge. Our results have implications for the development of medical countermeasures and for risk assessment for re-emerging WEEV strains.
  • No Thumbnail Available
    Publication
    Structural Basis for Continued Antibody Evasion by the SARS-CoV-2 Receptor-Binding Domain
    (2021-12-02) Nabel, Katherine G.; Clark, Sarah A.; Shankar, Sundaresh; Pan, Junhua; Clark, Lars; Yang, Pan; Coscia, Adrian; McKay, Lindsay G.A.; Varnum, Haley; Brusic, Vesna; Tolan, Nicole V.; Zhou, Guohai; Desjardins, Michaël; Turbett, Sarah E.; Kanjilal, Sanjat; Sherman, Amy; Dighe, Anand; LaRocque, Regina C.; Ryan, Edward; Tylek, Casey; Cohen-Solal, Joel F.; Darcy, Andhao T.; Tavella, Davide; Clabbers, Anca; Fan, Yao; Griffiths, Anthony; Correia, Ivan R.; Seagal, Jane; Baden, Lindsey; Charles, Richelle; Abraham, Jonathan
    Many studies have examined the impact of SARS-CoV-2 variants on neutralizing antibody activity after they have become dominant strains. Here, we evaluate the consequences of further viral evolution. We demonstrate mechanisms through which the SARS-CoV-2 receptor-binding domain (RBD) can tolerate large numbers of simultaneous antibody escape mutations and show that pseudotypes containing up to seven mutations, as opposed to the one to three found in previously studied variants of concern, are more resistant to neutralization by therapeutic antibodies and serum from vaccine recipients. We identify an antibody that binds the RBD core to neutralize pseudotypes for all tested variants but show that the RBD can acquire an N-linked glycan to escape neutralization. Our findings portend continued emergence of escape variants as SARS-CoV-2 adapts to humans.